What's breaking now, across thousands of outlets.
NYU Langone Health and Dana-Farber Cancer Institute built an oncology decision support platform to guide clinicians through treatment decisions. Now, the institutions are commercializing the product so other health systems can use it too.
We haven't written up this one. Healthcare Dive has the full story — the link below goes straight to it.
Type 2 diabetes is associated with an increased risk of heart disease. Many people with type 2 diabetes are prescribed blood sugar-lowering medication to reduce this risk.
Roivant Chief Executive Officer Matt Gline expects the FDA to approve the launch of a drug used to fight a debilitating skin disease. He says the drug should be on the market by September.
This, after the country has been condemned for the hundreds of healthcare units it has struck in Gaza after October 7, 2023
One of the hallmarks of Alzheimer's disease is the accumulation of a peptide in the brain known as amyloid beta. A new study published in Nature Communications on July 22 has uncovered the atomic…
A victim of a road accident was treated in a startling manner at the Manjhaul Sub-Divisional Hospital, located in Begusarai, Bihar, where a medicine carton served as a splint.
Contributions increased by 647 percent between 2024 and 2025, rising from Sh249.15 million in...
